Literature DB >> 2880914

Isolation of the MHC genes encoding the tumour-specific class I antigens expressed on a murine fibrosarcoma.

H J Stauss, R Linsk, A Fischer, S Watts, D Banasiak, A Haberman, I Clark, J Forman, M McMillan, H Schreiber.   

Abstract

The C3H UV-induced fibrosarcoma, 1591, is highly immunogenic and, therefore, is readily rejected when transplanted into immunocompetent syngeneic recipients. Previous analysis of 1591 with tumour-specific or H-2-reactive monoclonal antibodies revealed that this antigenicity might be due to the expression of two novel class I major histocompatibility complex (MHC) antigens. In this report we describe the molecular cloning and initial characterization of three genes which account for all of the unique serological class I reactivities observed on this tumour. These include two distinct, but highly conserved, H-2L-like genes, and a third gene the product of which bears determinants which are characteristic of both the tumour and of class I products of the H-2k haplotype. Moreover, each of these genes contains a polymorphic restriction enzyme fragment which is detected in the class I sequences of 1591 relative to normal C3H tissue. Since the expression of these polymorphic class I sequences is relevant to the immunogenicity of 1591, the mutational events by which these genes were generated may be significant to the immunobiology of this tumour.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2880914     DOI: 10.1111/j.1744-313x.1986.tb01090.x

Source DB:  PubMed          Journal:  J Immunogenet        ISSN: 0305-1811


  8 in total

1.  Allospecific cytotoxic T lymphocytes recognize an H-2 peptide in the context of a murine major histocompatibility complex class I molecule.

Authors:  E S Song; R Linsk; C A Olson; M McMillan; R S Goodenow
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

2.  A highly immunogenic tumor transfected with a murine transforming growth factor type beta 1 cDNA escapes immune surveillance.

Authors:  G Torre-Amione; R D Beauchamp; H Koeppen; B H Park; H Schreiber; H L Moses; D A Rowley
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

3.  Antigen(s)-specific tumour-infiltrating lymphocytes from tumour induced by human herpes virus-6 (HHV-6) DNA transfected NIH 3T3 transformants.

Authors:  R K Puri; P Leland; A Razzaque
Journal:  Clin Exp Immunol       Date:  1991-01       Impact factor: 4.330

4.  Tumor antigens defined by cloned immunological probes are highly polymorphic and are not detected on autologous normal cells.

Authors:  P L Ward; H Koeppen; T Hurteau; H Schreiber
Journal:  J Exp Med       Date:  1989-07-01       Impact factor: 14.307

5.  The tumor-rejection antigens of the 1591 ultraviolet fibrosarcoma. Potential origin and evolutionary implications.

Authors:  R Linsk; S Watts; A Fischer; R S Goodenow
Journal:  J Exp Med       Date:  1989-03-01       Impact factor: 14.307

6.  Molecular characterization of the C3HfB/HeN H-2Kkm2 mutation. Implications for the molecular basis of alloreactivity.

Authors:  J M Vogel; A C Davis; D M McKinney; M McMillan; W J Martin; R S Goodenow
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

7.  Animals bearing malignant grafts reject normal grafts that express through gene transfer the same antigen.

Authors:  G A Perdrizet; S R Ross; H J Stauss; S Singh; H Koeppen; H Schreiber
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

8.  Stroma is critical for preventing or permitting immunological destruction of antigenic cancer cells.

Authors:  S Singh; S R Ross; M Acena; D A Rowley; H Schreiber
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.